Breast Cancer Research and Treatment

, Volume 38, Issue 3, pp 299–303 | Cite as

A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family

  • Bettina Staats
  • Ulrich Bonk
  • Sylke Wanschura
  • Peter Hanisch
  • Eric F. P. M. Schoenmakers
  • Wim J. M. Van de Ven
  • Sabine Bartnitzke
  • Jörn Bullerdiek


An intracanalicular fibroadenoma of the breast showing a clonal chromosomal aberration t(4;12) (q27;q15) as the sole cytogenetic abnormality is described. In order to narrow down the breakpoint region on chromosome 12 on the molecular level we performed fluorescencein situ hybridization (FISH) analysis with a cosmid pool originating from a YAC-contig overspanning part of the region 12q14–15. We were able to narrow down the breakpoint to an approximately 230kb fragment belonging to the HMGI-C gene which maps within an area recently designated as MAR (Multiple Aberration Region). The chromosomal breakpoints of other frequent benign solid tumors, i.e. lipomas, uterine leiomyomas, and pleomorphic adenomas are clustered within the third intron of that gene.

Key words

chromosome 12 fibroadenoma mesenchymal growth 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Haagensen CD: Diseases of the Breast. Saunders, New York, 1986, pp 267–312Google Scholar
  2. 2.
    Calabrese G, Di Virgillio C, Cianchetti E, Franchi PG, Stuppia L, Parruti G, Bianchi PC, Palka G: Chromosome abnormalities in breast fibroadenomas. Genes Chrom Cancer 3: 202–204, 1991PubMedGoogle Scholar
  3. 3.
    Ozisik YY, Meloni AM, Stephenson CF, Peier A, Moore GE, Sandberg AA: Chromosome abnormalities in breast fibroadenomas. Cancer Genet Cytogenet 77: 125–128, 1994PubMedGoogle Scholar
  4. 4.
    Leuschner E, Meyer-Bolte K, Caselitz J, Bartnitzke S, Bullerdiek J: Fibroadenoma of the breast showing a translocation (6;14), a ring chromosome and two markers involving parts of chromosome 11. Cancer Genet Cytogenet 76: 145–147, 1994PubMedGoogle Scholar
  5. 5.
    Rohen C, Staats B, Bonk U, Bartnitzke S, Bullerdiek J: The significance of clonal chromosome aberrations in breast fibroadenomas. Cancer Genet Cytogenet, in pressGoogle Scholar
  6. 6.
    Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA: Cytogenetic studies of adipose tissue tumors. I. A benign lipoma with reciprocal translocation t(3;12) (q28;q14). Cancer Genet Cytogenet 23: 283–289, 1986PubMedGoogle Scholar
  7. 7.
    Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F: Chromosomal rearrangements in chondromatous tumors. Cancer 65: 242–248, 1989Google Scholar
  8. 8.
    Mark J, Dahlenfors R, Ekedahl C: Chromosomal deviations and their specificity in human mixed salivary gland tumours. Anticancer Res 1: 49–57, 1981Google Scholar
  9. 9.
    Bullerdiek J, Bartnitzke S, Weinberg M, Chilla R, Haubrich J, Schloot W: Rearrangements of chromosome 12q13–q15 in pleomorphic adenomas of the human salivary gland (PSA). Cytogenet Cell Genet 45: 187–190, 1987PubMedGoogle Scholar
  10. 10.
    Heim S, Nilbert M, Vanni R, Floderus U-M, Mandahl N, Lecca U, Mitelman F: A specific translocation t(12;14) (q13–15;q13–24), characterizes a subgroup of uterine leiomyomas. Cancer Genet Cytogenet 32: 13–17, 1988PubMedGoogle Scholar
  11. 11.
    Sandros J, Stenman G, Mark J: Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 44: 153–167, 1990PubMedGoogle Scholar
  12. 12.
    Vanni R, Lecca U: Involvement of the long arm of chromosome 12 chromosome rearrangement of uterine leiomyoma. Cancer Genet Cytogenet 32: 33–34, 1988PubMedGoogle Scholar
  13. 13.
    Mark J, Havel G, Grepp C, Dahlenfors R, Wedell B: Cytogenetical observations in human benign uterine leiomyomas. Anticancer Res 8: 621–626, 1988PubMedGoogle Scholar
  14. 14.
    Nilbert M, Heim S, Mandahl N, Floderus U-M, Willen H, Mitelman F: Characteristic chromosome abnormalities, including rearrangements of 6p, del (7q), + 12, and t(12;14), in 44 uterine leiomyomas. Hum Genet 85: 605–611, 1990PubMedGoogle Scholar
  15. 15.
    Stern C, Deichert U, Thode B, Bartnitzke S, Bullerdiek J: Eine zytogenetische Subtypisierung von 139 Uterus-Leiomyomen. Geburtsh und Frauenheilk 52: 762–772, 1992Google Scholar
  16. 16.
    Vanni R, Dal Cin P, Marras S, Moerman P, Andria M, Valdes E, Deprest J, Van den Berghe H: Endometrial polyp: another benign tumor characterized by 12q13–15 changes. Cancer Genet Cytogenet 68: 32–33, 1993PubMedGoogle Scholar
  17. 17.
    Heim S, Mandahl N, Kristoffersson U, Mitelman F, Rööser B, Rydholm A, Willen H: Reciprocal translocation t(3;12) (q27;q13) in lipoma. Cancer Genet Cytogenet 23: 301–304, 1986PubMedGoogle Scholar
  18. 18.
    Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F: Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 79: 203–208, 1988PubMedGoogle Scholar
  19. 19.
    Dal Cin P, Kools P, De Jonge I, Moerman PH, Van de Ven W, Van den Berghe H: Rearrangements of 12q14–15 in pulmonary chondroid hamartoma. Genes Chrom Cancer 8: 131–133, 1993PubMedGoogle Scholar
  20. 20.
    Van de Ven WJM, Wanschura S, Schoenmakers EFPM, Kazmierczak B, Kools PFJ, Geurts JWM, Bartnitzke S, Van den Berghe H, Bullerdiek J: Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13–q15 implicated in various solid tumors. Genes Chrom Cancer 12: 296–303, 1995PubMedGoogle Scholar
  21. 21.
    Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM: Recurrent rearrangements in the high mobility group protein gene HMGI-C in a variety of benign mesenchymal tumors. Nat Genet 10: 436–444, 1995PubMedGoogle Scholar
  22. 22.
    Seabright M: A rapid banding technique for human chromosomes. Lancet i: 971–972, 1971Google Scholar
  23. 23.
    Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S: Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 65: 64–67, 1993PubMedGoogle Scholar
  24. 24.
    ISCN: Guidelines for cancer cytogenetics. Supplement to an international system of human cytogenetic nomenclature. Mitelman F (ed) Karger, Basel (1991)Google Scholar
  25. 25.
    Kievitz T, Dauwerse JG, Wiegant J, Devilee P, Breuning MH, Cornelisse CJ, van Ommen GJB, Pearson PL: Rapid subchromosomal localization of cosmids by nonradioactivein situ hybridization. Cytogenet Cell Genet 53: 134–136, 1990PubMedGoogle Scholar
  26. 26.
    Schoenmakers EFPM, Kools PFJ, Mols R, Kazmierczak B, Bartnitzke S, Dal Cin P, De Jong PJ, Van den Berghe H, Van de Ven WJM: Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma. Genomics 20: 210–222, 1993Google Scholar
  27. 27.
    Montgomery KT, Le Blanc JM, Tsai P, McNinch JS, Ward DC, De Jong PJ, Kucherlapati R, Krauter KS: Characterization of two chromosome 12 cosmid libraries and development of STSs from cosmids mapped by FISH. Genomics 17: 682–693, 1993PubMedGoogle Scholar
  28. 28.
    Albertsen HM, Adderrahim H, Cann HM, Dausset J, Le Paslier D, Cohen D: Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci USA 87: 4256–4260, 1990PubMedGoogle Scholar
  29. 29.
    Schoenmakers EFPM, Mols R, Wanschura S, Kools PFJ, Geurts JMW, Bartnitzke S, Bullerdiek J, Van den Berghe H, Van den Ven WJM: Identification, molecular cloning and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas. Genes Chrom Cancer 11: 106–118, 1994PubMedGoogle Scholar
  30. 30.
    Wanschura S, Kazmieczak B, Schoenmakers E, Meyen E, Bartnitzke S, Van de Ven W, Bullerdiek J, Schloot W: Regional fine mapping of the multiple aberration region involved in uterine leiomyoma, lipoma and pleomorphic adenoma of the salivary gland to 12q15. Genes Chrom Cancer, in pressGoogle Scholar
  31. 31.
    Wanschura S, Belge G, Stenman G, Kools P, Dal Cin P, Schoenmakers EFPM, Huysmans C, Bartnitzke S, Van de Ven WJM, Bullerdiek J: Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12. Cancer Genet Cytogenet, in pressGoogle Scholar
  32. 32.
    Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 53: 4071–4074, 1993PubMedGoogle Scholar
  33. 33.
    Birdsall SH, MacLennan KA, Gusterson BA: t(6;12) (q23;q13) and t(10;16) (q22;p11) in a phyllodes tumor of breast. Cancer Genet Cytogenet 60: 74–77, 1992PubMedGoogle Scholar
  34. 34.
    Dietrich CU, Pandis N, Bardi G, Teixeira MR, Soukhikh T, Petersson C, Andersen JA, Heim S: Karyotypic changes in phyllodes tumors of the breast. Cancer Genet Cytogenet 78: 200–206, 1994PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Bettina Staats
    • 1
  • Ulrich Bonk
    • 2
  • Sylke Wanschura
    • 1
  • Peter Hanisch
    • 2
  • Eric F. P. M. Schoenmakers
    • 3
  • Wim J. M. Van de Ven
    • 3
  • Sabine Bartnitzke
    • 1
  • Jörn Bullerdiek
    • 1
  1. 1.Center for Human Genetics and Genetic CounsellingUniversity of BremenBremenGermany
  2. 2.Institute for PathologyCentral Hospital Bremen-NordBremenGermany
  3. 3.Center for Human GeneticsUniversity of LeuvenLeuvenBelgium

Personalised recommendations